Toxic Dose of Fluoxetine in a 17-Year-Old
There is no clearly defined toxic dose of fluoxetine in adolescents, but ingestions as low as 520 mg have been associated with lethal outcomes in adults, while the largest documented pediatric ingestion was 3 grams (which was non-lethal). 1
Key Toxicity Information
Documented Overdose Data in Adolescents
The FDA drug label provides critical overdose data specific to pediatric patients (ages 3 months to 17 years):
- 156 total overdose cases involving fluoxetine alone or in combination
- Largest pediatric ingestion: 3 grams (non-lethal) 1
- 6 fatalities occurred, but all involved mixed-drug ingestions or other suicide methods
- One notable fatality: a 9-year-old on chronic 100 mg/day fluoxetine (with clonidine, methylphenidate, promethazine) who experienced metabolic toxicity, seizures, status epilepticus, and cardiac arrest 1
Dose-Related Toxicity Thresholds
For acute single ingestions:
- 600-1200 mg (10-19.5 mg/kg): Recent case series showed generalized seizures occurring 3-9 hours post-ingestion at these doses in adolescents 2
- >1000 mg: Most reported seizures in the literature occur at this threshold or higher, typically 1-16 hours post-ingestion 2
- 520 mg: Lowest adult dose associated with lethal outcome (though causality not definitively established) 1
Clinical Manifestations of Toxicity
Common Non-Fatal Symptoms
The most frequently reported signs and symptoms include 1:
- Seizures (most concerning)
- Somnolence
- Nausea and vomiting
- Tachycardia
- Tremor
Serious Adverse Events
Life-threatening complications can include 1:
- Seizures (including status epilepticus)
- Serotonin syndrome (confusion, agitation, neuromuscular hyperactivity, autonomic instability)
- Cardiac effects: QT prolongation, ventricular tachycardia, torsades de pointes
- Neuroleptic malignant syndrome-like events
- Coma, delirium, stupor
- Hypotension
- Pyrexia
Critical Management Considerations
Time Course of Toxicity
Prolonged monitoring is essential due to fluoxetine's pharmacokinetics:
- Half-life of fluoxetine: ~7 days
- Half-life of active metabolite norfluoxetine: up to 17.5 days 3
- Serotonin toxicity can persist for 10+ days after acute ingestion 3
- Seizures typically occur 3-16 hours post-ingestion 2
Monitoring Requirements
For any suspected fluoxetine overdose in a 17-year-old:
- Continuous cardiac monitoring (ECG for QT prolongation, arrhythmias) 1
- Vital signs with focus on heart rate, blood pressure, temperature
- Mental status assessment for serotonin toxicity (agitation, confusion, neuromuscular hyperactivity)
- Creatine kinase levels (rhabdomyolysis risk) 4
- Observation period of at least 24 hours, but potentially much longer given the drug's half-life
Treatment Approach
- Supportive care is primary treatment 1
- Ensure adequate airway, oxygenation, ventilation
- Activated charcoal if presenting soon after ingestion
- Avoid emesis induction 1
- Gastric lavage only if performed soon after ingestion in symptomatic patients
- Benzodiazepines (diazepam) for seizure management 1
- Cyproheptadine for serotonin syndrome 3
- External cooling for hyperthermia 3
- Forced diuresis, dialysis, and hemoperfusion are not beneficial due to large volume of distribution 1
Important Caveats
CYP2D6 poor metabolizers are at higher risk for toxicity even at therapeutic doses, as norfluoxetine inhibits CYP2D6, which metabolizes fluoxetine—creating a self-perpetuating cycle of drug accumulation 5. However, the case report of prolonged serotonin toxicity occurred in a patient with normal CYP2D6 phenotype 3, indicating that genetic testing does not eliminate risk.
Co-ingestions dramatically increase risk: All 6 pediatric fatalities involved multiple drugs 1. The margin of safety is significantly reduced when fluoxetine is combined with other serotonergic agents, CNS depressants, or drugs that prolong QT interval.
Chronic dosing context matters: The 9-year-old fatality was on chronic high-dose fluoxetine (100 mg/day for 6 months), suggesting that baseline steady-state levels combined with additional ingestion may lower the threshold for life-threatening toxicity 1.